← Back to All US Stocks

CRGT Stock Analysis - Cortigent, Inc. AI Rating

CRGT Electromedical & Electrotherapeutic Apparatus DE CIK: 0001958489
Recently Updated • Analysis: Mar 23, 2026 • SEC Data: 2026-03-23
AI Rating
SELL
95% Confidence

📊 CRGT Key Takeaways

Revenue: N/A
Net Margin: N/A
Free Cash Flow: N/A
Current Ratio: N/A
Debt/Equity: N/A
EPS: $0.00
AI Rating: SELL with 95% confidence

Investment Thesis

Cortigent, Inc. presents an uninvestable profile due to complete absence of financial data across all fundamental metrics. The company shows no revenue generation, no profitability data, and minimal operational activity, indicating either pre-revenue stage, dormant status, or reporting deficiencies that preclude meaningful fundamental analysis.

CRGT Strengths

  • -No strengths identified

CRGT Risks

  • ! No revenue or financial performance data available
  • ! Unable to assess profitability, liquidity, or solvency metrics
  • ! No insider activity or engagement signals in past 90 days
  • ! Complete absence of operational cash flow data
  • ! Cannot evaluate financial health or operational viability

Key Metrics to Watch

CRGT Financial Metrics

Revenue
N/A
Net Income
N/A
EPS (Diluted)
$0.00
Free Cash Flow
N/A
Total Assets
N/A
Cash Position
N/A

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

CRGT Profitability Ratios

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA N/A
FCF Margin N/A

CRGT vs Healthcare Sector

How Cortigent, Inc. compares to Healthcare sector averages

Net Margin
CRGT 0.0%
vs
Sector Avg 12.0%
CRGT Sector
ROE
CRGT 0.0%
vs
Sector Avg 15.0%
CRGT Sector
Current Ratio
CRGT 0.0x
vs
Sector Avg 2.0x
CRGT Sector
Debt/Equity
CRGT 0.0x
vs
Sector Avg 0.6x
CRGT Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

CRGT Balance Sheet & Liquidity

Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
N/A
Debt/Assets
0.0%
Interest Coverage
N/A
Long-term Debt
N/A

CRGT Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
N/A
Free cash flow / Revenue

CRGT SEC Filings

Access official SEC EDGAR filings for Cortigent, Inc. (CIK: 0001958489)

📋 Recent SEC Filings

Date Form Document Action
Mar 17, 2026 S-1/A g085456_s1a.htm View →
Mar 3, 2026 S-1/A g085138_s1a.htm View →
Jan 9, 2026 S-1/A g085074_s1a.htm View →
Dec 2, 2025 S-1/A g085026_s1a.htm View →
Dec 11, 2024 S-1/A g084589_s1a.htm View →

Frequently Asked Questions about CRGT

What is the AI rating for CRGT?

Cortigent, Inc. (CRGT) has an AI rating of SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.

What are CRGT's key strengths?

.

What are the risks of investing in CRGT?

No revenue or financial performance data available. Unable to assess profitability, liquidity, or solvency metrics.

What is CRGT's revenue and growth?

Cortigent, Inc. reported revenue of N/A.

Does CRGT pay dividends?

Cortigent, Inc. does not currently pay dividends.

Where can I find CRGT SEC filings?

Official SEC filings for Cortigent, Inc. (CIK: 0001958489) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is CRGT's EPS?

Cortigent, Inc. has a diluted EPS of $0.00.

How is the AI analysis conducted?

Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.

Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 23, 2026 | Data as of: 2026-03-23 | Powered by Claude AI